SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009799
Filing Date
2022-05-13
Accepted
2022-05-13 08:01:22
Documents
75
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adgi-20220331.htm   iXBRL 10-Q 2712594
2 EX-31.1 adgi-ex31_1.htm EX-31.1 23474
3 EX-31.2 adgi-ex31_2.htm EX-31.2 24071
4 EX-32.1 adgi-ex32_1.htm EX-32.1 15036
5 EX-32.2 adgi-ex32_2.htm EX-32.2 15037
  Complete submission text file 0000950170-22-009799.txt   8546031

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adgi-20220331.xsd EX-101.SCH 56510
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adgi-20220331_lab.xml EX-101.LAB 442888
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adgi-20220331_cal.xml EX-101.CAL 39242
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adgi-20220331_pre.xml EX-101.PRE 350692
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adgi-20220331_def.xml EX-101.DEF 194455
69 EXTRACTED XBRL INSTANCE DOCUMENT adgi-20220331_htm.xml XML 1320281
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 22920298
SIC: 2836 Biological Products, (No Diagnostic Substances)